Mergers & Acquisitions ·
Clarivate completes sale of Life Sciences and Healthcare business for $600M
CLVTClarivate PLC
Clarivate Plc completed the previously announced sale of its Life Sciences and Healthcare business to an affiliate of Altaris, LLC on October 6, 2026. The transaction carries an aggregate purchase price of $600 million, structured as approximately $488.4 million in cash at closing (net of costs and working capital adjustments), a $75 million unsecured senior note, and $25 million in deferred cash consideration payable by January 31, 2028. Clarivate intends to use the proceeds for partial redemptions of its Senior Secured Notes due 2028 and Senior Notes due 2029. The divested unit is classified as discontinued operations, with a transition services agreement in place to support Altaris post-closing. Clarivate Plc operates in the information analytics industry.